Updated Jul 16, 2026
Boyle Scott N is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 7.3K | $1.89 | $14K |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 20.9K | $0.00 | |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 1.7K | $1.89 | $3K |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 5.0K | $0.00 | |
| 2026-02-18 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 200.0K | $0.00 | |
| 2024-11-12 | CCCC | C4 Therapeutics, Inc. | F — Tax withholding / forfeiture | 1.1K | $6.04 | $7K |
| 2024-11-12 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 3.8K | — |
Boyle Scott N is a corporate insider — currently tracked as Chief Business Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Boyle Scott N profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.